A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system-Reference-Cited by-同舟云学术

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system

Published:2018-01-19 Issue:1 Volume:3 Page:
ISSN:2059-0105
Container-title:npj Vaccines
language:en
Short-container-title:npj Vaccines

Author:

Pankrac Joshua,Klein Katja,McKay Paul F.^ORCID,King Deborah F. L.,Bain Katie,Knapp Jason,Biru Tsigereda,Wijewardhana Chanuka N.,Pawa Rahul,Canaday David H.,Gao Yong,Fidler Sarah,Shattock Robin J.,Arts Eric J.,Mann Jamie F. S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Link

http://www.nature.com/articles/s41541-017-0040-6.pdf

Reference37 articles.

1. Lederman, M. M. et al. A cure for HIV infection: “not in my lifetime” or “just around the corner”? Pathog. Immun. 1, 154–164 (2016).

2. Rerks-Ngarm, S. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209–2220 (2009).

3. Cohen, K. W. & Frahm, N. Current views on the potential for development of a HIV vaccine. Expert. Opin. Biol. Ther. 17, 295–303 (2017).

4. Stephenson, K. E., D’Couto, H. T. & Barouch, D. H. New concepts in HIV-1 vaccine development. Curr. Opin. Immunol. 41, 39–46 (2016).

5. Santra, S. et al. Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens. Virology 428, 121–127 (2012).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective and targeted latency reversal in CD4 ⁺ T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infection;Emerging Microbes & Infections;2024-03-26

2. Protein‐Based Controllable Nanoarchitectonics for Desired Applications;Advanced Functional Materials;2024-03-19

3. A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?;Viruses;2024-02-01

4. HIV Latency and Nanomedicine Strategies for Anti-HIV Treatment and Eradication;Biomedicines;2023-02-18

5. Virus-Like particles as a Novel Targeted Drug Delivery Platform for Biomedical Applications;Research Journal of Pharmacy and Technology;2022-06-28